Unlocking Global Market Access



Presented exclusively for members of the California Life Sciences Association

Please complete the form below to view the webinar recording. 

Name *
Communication Preferences
Thank you for your interest in Context Matters. You will receive future communications. To opt-out, check the box below.

Thinking about taking your drug overseas? Early decisions made during clinical trial design are inextricably linked to later evaluations of drug cost-effectiveness by international health technology assessment (HTA) agencies--one of the critical differences from a US-only strategy. This webinar provides an insightful discussion exploring the specific challenges to global market access for biotechnology companies including:

  • How do HTA agencies function within their healthcare systems and relate to reimbursement?

  • What are the requirements of HTA agencies and key drivers of decision-making?

  • What are the important clinical and economic considerations during development?

  • How can historical HTA data inform strategies and requirements for new drugs entering the market?